IP Library › Assignment 059845/0839
Patent Assignment
Reel/Frame 059845/0839

Articles of Continuance & Certificate of Discontinuance

Recorded: 2022-03-14 Pages: 13
Assignor
ANTIBE HOLDINGS INC.
Executed: 2021-05-28
Assignee
ANTIBE HOLDINGS INC.
15 PRINCE ARTHUR AVENUE, TORONTO, M5R 1B2, CANADA
Covered Properties (3)
Derivatives of 4-or 5-Aminosalicylic Acid
Patent: 7,910,568 →
Application: 11/915,305 →
Publication: US 2008/0207564
Derivatives of 4- or 5-Aminosalicylic Acid
Patent: 7,879,827 →
Application: 12/368,846 →
Publication: US 2009/0233886
Derivatives of 4- or 5-Aminosalicylic Acid
Patent: 8,114,857 →
Application: 12/980,985 →
Publication: US 2011/0130368
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 10, 2008
From: WALLACE, JOHN L.; CIRINO, GIUSEPPE; CALIENDO, GIUSEPPE; SPARATORE, ANNA
To: ANTIBE THERAPEUTICS INC.
Reel/Frame 020346/0954 →
Assignment of Assignor's Interest Mar 11, 2009
From: WALLACE, JOHN L.; CIRINO, GIUSEPPE; CALIENDO, GIUSEPPE; SPARATORE, ANNA
To: ANTIBE THERAPEUTICS INC.
Reel/Frame 022378/0888 →
Assignment of Assignor's Interest Dec 29, 2010
From: WALLACE, JOHN L.; CIRINO, GIUSEPPE; CALIENDO, GIUSEPPE; SPARATORE, ANNA
To: ANTIBE THERAPEUTICS INC.
Reel/Frame 025555/0663 →
Change of Name Nov 5, 2013
From: ANTIBE THERAPEUTICS INC.
To: ANTIBE HOLDINGS INC.
Reel/Frame 031580/0142 →
Merger Mar 14, 2022
From: ANTIBE AMALCO INC.; ANTIBE THERAPEUTICS INC.
To: ANTIBE THERAPEUTICS INC.
Reel/Frame 059808/0216 →
Merger and Change of Name Mar 14, 2022
From: ANTIBE HOLDINGS INC.; 2831094 ONTARIO INC.; ANTIBE AMALCO INC.
To: ANTIBE AMALCO INC.
Reel/Frame 059365/0019 →